Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a special chair help stop leakage? new study tests electromagnetic pelvic floor therapy

NCT ID NCT07260604

Symptom relief Sponsor: Göteborg University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 16, 2026 · Updated 2 times

Summary

This study tests whether adding a non-invasive electromagnetic chair treatment (HIFEM) to standard pelvic floor training can better reduce urine leakage in women aged 65-85 with daily stress incontinence. One hundred participants will be randomly assigned to either pelvic floor training alone or training plus ten 30-minute HIFEM sessions. The goal is to see if the combination reduces leakage, the need for incontinence products, and improves quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 to 85 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women aged 65-85 ears * Having daily stress incontinence requiring use of incontinence aids. * Living in ordinary housing without home (health-) care * Being physically active and can move independently both indoors and outdoors. * Being able to give independent informed consent in speech and writing * To understand and follow instructions in one of following languages Swedish, Arabic, French, and/or English Exclusion Criteria: * -Ongoing coached pelvic floor training * Heart disease where treatment is contraindicated * Lung disease with chronic cough * Pacemaker, defibrillator, neurostimulator, medication pump, and implanted devices in the head or spinal cord * Electronic or metal implants in the abdomen, hips, or knees * Epilepsy * Ongoing cancer * Stoma or abdominal hernia * Ongoing treatment with anticoagulants such as warfarin, medicines affecting the bladder such as muscarin receptor antagonist, diuretics and local oestrogen which affect the bladder and urine production. * infection, fever, bleeding, or pain in the lower abdomen * Skin diseases or any skin sensitivity * BMI exceeding 30 kg/m2

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Urinary incontinence (UI) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

female stress incontinence Urinary Incontinence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Urinary incontinence (UI)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Gothenburg university

    Gothenburg, 405 30, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.